Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections.

Infect Drug Resist · 2026 · PMC13109066 · PMID 42037745

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although 30-day mortality was also lower in the cefiderocol group, the difference did not reach statistical significance (35% vs. 52%).

also in 111,027 other papers

showed a trendno p-value reported

The analysis showed a trend toward lower mortality among patients treated with cefiderocol.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.